Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(450/week)
Manufacturing
(348/week)
Technology
(352/week)
Energy
(230/week)
Other Manufacturing
(292/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
UCB
Oct 17, 2019
Bimekizumab Phase 3 Psoriasis Study Meets All Endpoints, Achieving Significantly Greater Efficacy Versus Placebo and Ustekinumab
Oct 10, 2019
SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra Pharmaceuticals, Inc.
Aug 15, 2019
MyHealthTeams Raises $9.44 Million in Financing Round Led By Strategic Investor UCB
Jul 25, 2019
UCB Half Year Report 2019: UCB's Strong Performance Enables Continued Investment Into Future Growth Drivers
Jul 02, 2019
DEARhealth Announces Collaboration with UCB to Improve Care Delivery Through New Technology for Patients Living with Epilepsy
Jun 28, 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Jun 04, 2019
UCB Boston Research is Advancing Medical Innovation
May 20, 2019
Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss
Apr 09, 2019
FDA Approves EVENITY(TM) (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture
Mar 28, 2019
CIMZIA® (certolizumab pegol) is Now the First and Only U.S. FDA-Approved Treatment for Non-Radiographic Axial Spondyloarthritis
Mar 28, 2019
FDA approves treatment for patients with a type of inflammatory arthritis
Mar 11, 2019
Arthritis & Rheumatology Publishes the First Randomized Placebo-Controlled Study Over 52 Weeks in Non-Radiographic Axial Spondyloarthritis Showing Positive Results for CIMZIA® (certolizumab pegol)
Mar 06, 2019
UCB Ventures Appoints Alicia Irurzun-Lafitte as Partner
Feb 28, 2019
UCB Full Year Report 2018: 2018 Marks the Fifth Consecutive Year of Profitable Growth, Intensifying Investment in UCB's Strong Pipeline
Jan 30, 2019
Epilepsy - Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Jan 16, 2019
Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY(TM) (romosozumab)
Jan 08, 2019
EVENITY(TM) (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture
Jan 02, 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Nov 30, 2018
UCB presents latest research at 2018 American Epilepsy Society Annual Meeting demonstrating neurology commitment and leadership
Nov 13, 2018
Enable Injections Enters into Strategic Partnerships with UCB and Apellis Pharmaceuticals
‹‹
Page 2
››
Latest News
Mar 29, 2024
Anaergia Announces Delay in the Filing of Its Audited Financial Statements and Related Disclosures
Mar 29, 2024
Anaergia Announces Escrow Closing of Second Tranche of the Strategic Investment
Mar 29, 2024
Mandalay Resources Corporation Announces Filing of Annual Information Form and Updated NI 43-101 Technical...
Mar 29, 2024
AUGUSTA GOLD ANNOUNCES LOAN INCREASE AND EXTENSION; APPOINTMENT OF TY MINNICK AS INTERIM CFO
Mar 29, 2024
Wheaton Precious Metals Provides Details of Annual and Special Meeting of Shareholders and Files Form 40-F
Mar 29, 2024
Hot Stamping Foils Market size to grow by USD 177.96 million from 2022 to 2027, The use of hot foil stamping...
Mar 29, 2024
Australia Plastic Packaging Market Analysis, Industry Growth Forecasts 2019-2029, Featuring Orora Packaging...
Mar 29, 2024
Jereh Group stellt revolutionäre GreenWell-Anlagen zur Behandlung gefährlicher Abfälle auf der Beijing cippe...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events